Document 2145096

DAC-SPECTROMED S.R.L.
DAC – 2G
-2012,
, .
, .
, 47, . 64
.:/+37322/ 574900,574922/23;
: /+37322/ 574920
Email: office@dacspectromed.com
www.dacspectromed.com
PT MD 11-15796482-004:2006
«in vitro»
4068G 100 100
2-30
0
,
.
,
.
«
: 50 mg/dl
».
.
:
,
,
,
.
.
:
(>50 mg/dl)
.
(>40 mg/dl)
,
:
430
200 U,
<100 mg/dl
U,
.
12 mg.
, pH
:
.
,
,
: 10-15 mg/dl.
:
,
.
>9.
.
:
0,34 mg.
:
+
1.
2.
.
(15-30)
,
.
3.
-1
;
– 100
;
–1
.;
-1
-1
.
.
,
.
4.
,
;
:
).
2
0
2-30
.
,
b).
.
,
.
.
,
.
.
.
c).
.
.
,
.
.
.
.
.
d).
.
.
1-2
.
1
,
,
2
3
.
,
,
.
.
2-8°
.
,
,
,
.
100 mg/dl
.
.
,
,
,
.
26.11.2013
,
.
2
.
.
,
in vitro.
.
.
- NCCLS ( National Committee for Clinical Laboratory Standard)
GP 16-A/ ROUTINE URINALYSIS AND COLLECTION
TRANSPORATION AND PRESEVATION OF URINE
SPECIMENS; TRNTATIVE GUIDELINE VOL 12-NO 26, EC.1992
26.11.2013